The Market Reports

Index

1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Product Overview and Scope of Basal Insulin (Long-Acting Insulin)
1.2 Basal Insulin (Long-Acting Insulin) Segment by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) Segment by Application
1.3.1 Basal Insulin (Long-Acting Insulin) Sales Comparison by Application: (2021-2027)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2016-2027
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2016-2027
1.4.3 Basal Insulin (Long-Acting Insulin) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Sites, Area Served, Product Type
2.5 Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.5.1 Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue
2.5.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.3.1 North America Basal Insulin (Long-Acting Insulin) Sales by Country
3.3.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country
3.4.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Region
3.5.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region
3.5.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.6.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country
3.6.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country
3.7.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Basal Insulin (Long-Acting Insulin) Historic Market Analysis by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2016-2021)

5 Global Basal Insulin (Long-Acting Insulin) Historic Market Analysis by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2016-2021)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novo Nordisk Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Corporation Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Aventis Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Corporation Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biocon Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Julphar
6.5.1 Julphar Corporation Information
6.5.2 Julphar Description and Business Overview
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Julphar Product Portfolio
6.5.5 Julphar Recent Developments/Updates
6.6 Exir
6.6.1 Exir Corporation Information
6.6.2 Exir Description and Business Overview
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Exir Product Portfolio
6.6.5 Exir Recent Developments/Updates
6.7 Sedico
6.6.1 Sedico Corporation Information
6.6.2 Sedico Description and Business Overview
6.6.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sedico Product Portfolio
6.7.5 Sedico Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Corporation Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Wockhardt Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates

7 Basal Insulin (Long-Acting Insulin) Manufacturing Cost Analysis
7.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
7.4 Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Basal Insulin (Long-Acting Insulin) Distributors List
8.3 Basal Insulin (Long-Acting Insulin) Customers

9 Basal Insulin (Long-Acting Insulin) Market Dynamics
9.1 Basal Insulin (Long-Acting Insulin) Industry Trends
9.2 Basal Insulin (Long-Acting Insulin) Growth Drivers
9.3 Basal Insulin (Long-Acting Insulin) Market Challenges
9.4 Basal Insulin (Long-Acting Insulin) Market Restraints

10 Global Market Forecast
10.1 Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Type (2022-2027)
10.2 Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Application (2022-2027)
10.3 Basal Insulin (Long-Acting Insulin) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Basal Insulin (Long-Acting Insulin) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Basal Insulin (Long-Acting Insulin) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Basal Insulin (Long-Acting Insulin) Covered in This Study
Table 5. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers (2016-2021)
Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Sites and Area Served
Table 11. Manufacturers Basal Insulin (Long-Acting Insulin) Product Type
Table 12. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) & (K Units)
Table 16. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)
Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)
Table 19. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)
Table 20. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)
Table 22. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)
Table 24. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)
Table 32. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021)
Table 38. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2016-2021)
Table 39. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)
Table 40. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2016-2021)
Table 42. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2016-2021)
Table 44. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)
Table 45. Global Basal Insulin (Long-Acting Insulin) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2016-2021)
Table 47. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2016-2021)
Table 48. Novo Nordisk Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
Table 52. Novo Nordisk Recent Developments/Updates
Table 53. Sanofi Aventis Corporation Information
Table 54. Sanofi Aventis Description and Business Overview
Table 55. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
Table 57. Sanofi Aventis Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Biocon Corporation Information
Table 64. Biocon Description and Business Overview
Table 65. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Biocon Basal Insulin (Long-Acting Insulin) Product
Table 67. Biocon Recent Developments/Updates
Table 68. Julphar Corporation Information
Table 69. Julphar Description and Business Overview
Table 70. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Julphar Basal Insulin (Long-Acting Insulin) Product
Table 72. Julphar Recent Developments/Updates
Table 73. Exir Corporation Information
Table 74. Exir Description and Business Overview
Table 75. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Exir Basal Insulin (Long-Acting Insulin) Product
Table 77. Exir Recent Developments/Updates
Table 78. Sedico Corporation Information
Table 79. Sedico Description and Business Overview
Table 80. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Sedico Basal Insulin (Long-Acting Insulin) Product
Table 82. Sedico Recent Developments/Updates
Table 83. Wockhardt Corporation Information
Table 84. Wockhardt Description and Business Overview
Table 85. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Wockhardt Basal Insulin (Long-Acting Insulin) Product
Table 87. Wockhardt Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Basal Insulin (Long-Acting Insulin) Distributors List
Table 91. Basal Insulin (Long-Acting Insulin) Customers List
Table 92. Basal Insulin (Long-Acting Insulin) Market Trends
Table 93. Basal Insulin (Long-Acting Insulin) Growth Drivers
Table 94. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 95. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Share by Type in 2020 & 2027
Figure 3. Lantus Product Picture
Figure 4. Levemir Product Picture
Figure 5. Tresiba Product Picture
Figure 6. Toujeo Product Picture
Figure 7. Basaglar Product Picture
Figure 8. Biosimilar Glargines Product Picture
Figure 9. Global Basal Insulin (Long-Acting Insulin) Market Share by Application in 2020 & 2027
Figure 10. Type 1 Diabetes
Figure 11. Type 2 Diabetes
Figure 12. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Basal Insulin (Long-Acting Insulin) Market Size 2016-2027 (US$ Million)
Figure 14. Global Basal Insulin (Long-Acting Insulin) Sales 2016-2027 (K Units)
Figure 15. Global Basal Insulin (Long-Acting Insulin) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2020
Figure 17. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players: Market Share by Revenue in 2020
Figure 19. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)
Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2020
Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021)
Figure 23. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2020
Figure 24. U.S. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2016-2021)
Figure 49. Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application (2016-2021)
Figure 50. Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application in 2020
Figure 51. Revenue Share of Basal Insulin (Long-Acting Insulin) by Application (2016-2021)
Figure 52. Revenue Share of Basal Insulin (Long-Acting Insulin) by Application in 2020
Figure 53. Manufacturing Cost Structure of Basal Insulin (Long-Acting Insulin)
Figure 54. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
Figure 55. Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed